Literature DB >> 16114017

PIK3CA mutations in nasopharyngeal carcinoma.

Yvonne Yan-Yan Or, Angela Bik-Yu Hui, Ka-Fai To, Cleo Nga-Yee Lam, Kwok-Wai Lo.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16114017     DOI： 10.1002/ijc.21444

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  21 in total

Review 1.  Oncogenic mutations of PIK3CA in human cancers.

Authors:  Yardena Samuels; Todd Waldman
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

2.  The genomic landscape of nasopharyngeal carcinoma.

Authors:  De-Chen Lin; Xuan Meng; Masaharu Hazawa; Yasunobu Nagata; Ana Maria Varela; Liang Xu; Yusuke Sato; Li-Zhen Liu; Ling-Wen Ding; Arjun Sharma; Boon Cher Goh; Soo Chin Lee; Bengt Fredrik Petersson; Feng Gang Yu; Paul Macary; Min Zin Oo; Chan Soh Ha; Henry Yang; Seishi Ogawa; Kwok Seng Loh; H Phillip Koeffler
Journal:  Nat Genet       Date:  2014-06-22       Impact factor: 38.330

3.  Preclinical evaluation of the AKT inhibitor MK-2206 in nasopharyngeal carcinoma cell lines.

Authors:  Brigette B Y Ma; Vivian W Y Lui; Connie W C Hui; Cecilia P Y Lau; Chi-Hang Wong; Edwin P Hui; Margaret H Ng; S W Tsao; Yan Li; Anthony T C Chan
Journal:  Invest New Drugs       Date:  2012-11-11       Impact factor: 3.850

4.  EBV-related lymphomas: new approaches to treatment.

Authors:  Jennifer A Kanakry; Richard F Ambinder
Journal:  Curr Treat Options Oncol       Date:  2013-06

5.  The determinants of head and neck cancer: Unmasking the PI3K pathway mutations.

Authors:  Fernanda S Giudice; Cristiane H Squarize
Journal:  J Carcinog Mutagen       Date:  2013-08-02

6.  Preclinical evaluation of PI3K inhibitor BYL719 as a single agent and its synergism in combination with cisplatin or MEK inhibitor in nasopharyngeal carcinoma (NPC).

Authors:  Chi Hang Wong; Brigette Buig Yue Ma; Hio Teng Cheong; Connie Wun Chun Hui; Edwin Pun Hui; Anthony Tak Cheung Chan
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

7.  Novel mutant-enriched sequencing identified high frequency of PIK3CA mutations in pharyngeal cancer.

Authors:  Wanglong Qiu; Guo-Xia Tong; Spiros Manolidis; Lanny G Close; Adel M Assaad; Gloria H Su
Journal:  Int J Cancer       Date:  2008-03-01       Impact factor: 7.396

8.  PIK3CA mutations in mucinous cystic neoplasms of the pancreas.

Authors:  Dario Garcia-Carracedo; Zong-Ming Chen; Wanglong Qiu; Alicia S Huang; Sophia M Tang; Ralph H Hruban; Gloria H Su
Journal:  Pancreas       Date:  2014-03       Impact factor: 3.327

Review 9.  Epstein-Barr virus infection and nasopharyngeal carcinoma.

Authors:  Sai Wah Tsao; Chi Man Tsang; Kwok Wai Lo
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-10-19       Impact factor: 6.237

10.  PIK3CA mutation occurs in nasopharyngeal carcinoma but does not significantly influence the disease-specific survival.

Authors:  Chu-Chung Chou; Ming-Jen Chou; Chin-Yuan Tzen
Journal:  Med Oncol       Date:  2008-11-15       Impact factor: 3.064
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.